Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Your temperament may shape your menopause experience

NCT ID NCT06972290

Knowledge-focused Sponsor: Bagcilar Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether a woman's natural temperament (like being more anxious or upbeat) is linked to how severe her menopause symptoms are. Researchers surveyed 105 women going through menopause using two standard questionnaires. The goal was simply to understand connections, not to test any treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

105 people

The number who actually took part.

Started

Jan 2024

Finished

May 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women in the menopausal transition stage, classified as STRAW stages -1, +1a, and +1b, attending menopause outpatient clinics.

Ages

Up to 55 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women classified as STRAW stages -1, +1a, and +1b (menopausal transition stages) * Ability to complete questionnaires and provide informed consent Exclusion Criteria: * History of hormone therapy during the past 6 months * History of surgical menopause (bilateral oophorectomy) * Presence of severe physical disorders (e.g., malignancy, severe cardiovascular diseases) * Presence of severe psychological disorders (e.g., major depressive disorder, psychosis)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Menopause are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

personality disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Menopause Personality Temperament

Contacts and locations

Locations

  • Bağcılar Training and Reserach Hospital

    Istanbul, 34200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.